137 related articles for article (PubMed ID: 7745116)
21. mdm2: a bridge over the two tumour suppressors, p53 and Rb.
Yap DB; Hsieh JK; Chan FS; Lu X
Oncogene; 1999 Dec; 18(53):7681-9. PubMed ID: 10618708
[TBL] [Abstract][Full Text] [Related]
22. Expression of the Bcl-3 proto-oncogene suppresses p53 activation.
Kashatus D; Cogswell P; Baldwin AS
Genes Dev; 2006 Jan; 20(2):225-35. PubMed ID: 16384933
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.
Flenghi L; Bigerna B; Fizzotti M; Venturi S; Pasqualucci L; Pileri S; Ye BH; Gambacorta M; Pacini R; Baroni CD; Pescarmona E; Anagnostopoulos I; Stein H; Asdrubali G; Martelli MF; Pelicci PG; Dalla-Favera R; Falini B
Am J Pathol; 1996 May; 148(5):1543-55. PubMed ID: 8623923
[TBL] [Abstract][Full Text] [Related]
24. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.
Theodorescu D; Broder SR; Boyd JC; Mills SE; Frierson HF
J Urol; 1997 Jul; 158(1):131-7. PubMed ID: 9186339
[TBL] [Abstract][Full Text] [Related]
25. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity in cell proliferation and expression of p53 and bcl-2 during the indolent phase of germinal centre cell lymphoma: an explanation for clinical variability.
Barrans S; Randerson J; Evans P; Blythe D; Shiach C; Child JA; Morgan G; Jack AS
Br J Haematol; 1995 Aug; 90(4):830-6. PubMed ID: 7669661
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.
Yip HT; Chopra R; Chakrabarti R; Veena MS; Ramamurthy B; Srivatsan ES; Wang MB
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):317-26. PubMed ID: 16549753
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
29. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma.
Brynes RK; Wilson CS; Kim AB; McCourty A
Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle regulatory factors in juxta-tumoral renal parenchyma.
Petruşcă DN; Petrescu A; Vrabie C; Niculescu L; Jinga V; Diaconu C; Braşoveanu L
Rom J Morphol Embryol; 2005; 46(2):117-22. PubMed ID: 16286997
[TBL] [Abstract][Full Text] [Related]
31. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.
Gupta S; Afaq F; Mukhtar H
Oncogene; 2002 May; 21(23):3727-38. PubMed ID: 12032841
[TBL] [Abstract][Full Text] [Related]
32. Cell death in retinoblastoma: electron microscopic, immunohistochemical, and DNA fragmentation studies.
Cha SC; Suh KS; Song KS; Lim K
Ultrastruct Pathol; 2000; 24(1):23-32. PubMed ID: 10721149
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas.
Chetty R; O'Leary JJ; Biddolph SC; Gatter KC
J Clin Pathol; 1995 Mar; 48(3):239-41. PubMed ID: 7730485
[TBL] [Abstract][Full Text] [Related]
34. Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.
Shinohara H; Zhou J; Yoshikawa K; Yazumi S; Ko K; Yamaoka Y; Mizukami T; Yoshida T; Akinaga S; Tamaoki T; Motoda H; Benedict WF; Takahashi R
Br J Cancer; 2000 Oct; 83(8):1039-46. PubMed ID: 10993652
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric examination of DNA ploidy, p53 and bcl-2 expression in primary squamous epithelial pulmonary carcinoma.
Hołownia A; Kita J; Chyczewski L; Kozłowski M; Braszko JJ
Rocz Akad Med Bialymst; 1999; 44():180-9. PubMed ID: 10697433
[TBL] [Abstract][Full Text] [Related]
36. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
37. Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes.
Mercer WE; Baserga R
Exp Cell Res; 1985 Sep; 160(1):31-46. PubMed ID: 3930272
[TBL] [Abstract][Full Text] [Related]
38. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
[TBL] [Abstract][Full Text] [Related]
39. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
40. Regulation of p26-bcl-2 protein levels in human peripheral blood lymphocytes.
Reed JC; Miyashita T; Cuddy M; Cho D
Lab Invest; 1992 Oct; 67(4):443-9. PubMed ID: 1434528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
